search
Home > Reno jobs > Reno computer/technical

Posted: Saturday, December 23, 2017 7:48 AM


For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well:being of people across the globe. Whether your background is in life sciences, finance, IT, sales or another area, your skills will play an important role in the work e perform. In return, we'll help you build a career that you can feel passionate about.
Coordinate and facilitate proposal and letter of authorization processes to ensure smooth and timely business process flow by working with the marketing, scientific, and finance staff.
Independently provide central point of contact for assigned sponsor(s) and centralized, multi:site coordination for Charles River Laboratories, Preclinical Services Client Services response to sponsor requests.
Prepare sale price estimates for protocols, bid requests, study revisions and additions using site's suggested selling price.
Interact with scheduling to identify the dates for study initiation and assist with rescheduling studies, as needed.
Update database for business process milestones.
Follow up with clients to ensure that proposals are complete.
Prepare and distribute department status reports.
Ensure all legal documents are in place and accurate.
Assist with client visits, including giving company tours and presentations.
Provide backup assistance for the Account Manager.
About Safety Assessment
Charles River is committed to helping our partners expedite their preclinical drug development with exceptional safety assessment services, state:of:the:art facilities and expert regulatory guidance. From individual specialty toxicology and IND enabling studies to tailored packages and total laboratory support, our deeply experienced team can design and execute programs that anticipate challenges and avoid roadblocks for a smooth, efficient journey to market. Each year approximately 120 investigational new drug (IND) programs are conducted in our Safety Assessment facilities.
About Charles River
Charles River is an early:stage contract research organization (CRO). We have built upon our foundation of laboratory animal medicine and science to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non:GLP, to support clients from target identification through preclinical development. Charles River also provides a suite of products and services to support our clients' clinical laboratory testing needs and manufacturing activities. Utilizing this broad portfolio of products and services enables our clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness to increase speed to market.
With over 11,000 employees within 70 facilities in 18 countries around the globe, we are strategically positioned to coordinate worldwide resources and apply multidisciplinary perspectives in resolving our client's unique challenges. Our client base includes global pharmaceutical companies, biotechnology companies, government agencies and hospitals and academic institutions around the world. And in 2016, revenue increased by 23.3 to 1.68 billion from 1.36 billion in 2015.
At Charles River, we are passionate about our role in improving the quality of people's lives. Our mission, our excellent science and our strong sense of purpose guide us in all that we do, and we approach each day with the knowledge that our work helps to improve the health and well:being of many across the globe. We have proudly supported the development of 70 of the drugs approved by the FDA in 2016.
For more information, criver.
Charles River Laboratories, Inc. is an Equal Opportunity Employer M/F/Disabled/Vet

Source: https://www.tiptopjob.com/jobs/76230373_job.asp?source=backpage


• Location: Reno

• Post ID: 38749367 reno
reno.newsreview.com is an interactive computer service that enables access by multiple users and should not be treated as the publisher or speaker of any information provided by another information content provider. © 2018